A traveler in early infection will pass through undetected
As Ebola claims at least 131 lives across the Democratic Republic of Congo and Uganda, the world's wealthiest nations face a familiar crossroads: the impulse to be seen acting versus the discipline of acting wisely. Europe, watching the United States move toward airport screening and entry bans, is pausing to ask whether such measures protect populations or merely perform protection. The answer, epidemiologists suggest, lies not at the airport gate but in the quiet vigilance of a doctor's office and the unglamorous work of supporting those already fighting the outbreak at its source.
- A fast-moving Ebola outbreak has killed 131 people and infected 500 across DRC and Uganda, alarming global health authorities and triggering urgent policy debates on both sides of the Atlantic.
- The US has moved swiftly to impose passenger screening and entry bans, creating pressure on European governments — particularly Belgium, whose airport serves as the primary gateway between Europe and Kinshasa — to respond in kind.
- European virologists and the ECDC are pushing back, warning that airport temperature checks cannot catch travelers in the incubation period, and that broad flight restrictions may actually slow the humanitarian response while offering little real protection.
- Brussels Airlines continues flying its seven weekly Kinshasa routes under standard outbreak protocols, while Brussels Airport maintains a specialized military hospital evacuation plan should an infected passenger arrive.
- The emerging European strategy centers on clinician-level early warning — urging returning travelers with symptoms to immediately disclose their travel history — and on deploying ECDC experts directly to the DRC to strengthen the on-the-ground response.
The United States has responded to a new Ebola outbreak in the Democratic Republic of Congo and Uganda with airport passenger screening and entry restrictions for travelers from affected regions. The outbreak has killed at least 131 people and infected 500, prompting the WHO's director-general to describe its pace as deeply concerning. But as Washington moves toward visible border measures, Europe is asking a harder question: do those measures actually work?
Belgium finds itself at the center of the debate. Brussels Airport is Europe's main hub for flights to and from Kinshasa, with Brussels Airlines operating seven weekly routes on the corridor. Belgian virologist Steven Van Gucht acknowledged the heightened concern those direct connections warrant — but also noted that the historical risk to Europe has remained low, and that the biology of Ebola itself explains why airport screening has limits. The virus spreads only through contact with bodily fluids of someone who is actively symptomatic. During the incubation period — which can stretch up to twenty-one days — an infected traveler shows no fever and will pass any checkpoint undetected.
Celine Gossner of the ECDC reinforced this point, arguing that departure screening in affected countries is far more reliable than arrival checks in Europe, which consume significant resources for limited epidemiological return. Van Gucht conceded that entry screening might still serve a secondary function — as an early warning mechanism and a signal to the public that authorities are engaged — but he firmly opposed canceling flights, warning that such moves disrupt aid delivery and can discourage affected countries from reporting cases transparently.
The African CDC and the ECDC are aligned in opposing broad travel restrictions, and Europe's real preparation is happening elsewhere: in hospital protocols, in specialized evacuation plans at Brussels Airport, and in the instruction to returning travelers to seek immediate care if they develop symptoms within twenty-one days. The ECDC is already deploying experts to the DRC. The consensus among European health authorities is that the strongest defense is not a temperature gun at the gate, but a well-primed healthcare system and sustained support for the people fighting the outbreak where it lives.
The United States has shifted toward stricter health measures in response to a new Ebola outbreak spreading through the Democratic Republic of Congo and Uganda. This week, American officials announced passenger screening at airports and entry restrictions for travelers from affected regions. The move has prompted a harder question across Europe: should the continent follow suit, or are such measures more theater than epidemiology?
The outbreak is real. At least 131 people have died, with 500 confirmed cases. On Tuesday, the director-general of the World Health Organization called the scale and speed of the epidemic deeply concerning. Yet European health authorities are approaching the crisis differently than Washington, and the disagreement hinges on a fundamental question about how disease actually spreads.
Belgium sits at the center of this debate. Brussels Airport is Europe's primary gateway to and from Kinshasa, the capital of the DRC. Brussels Airlines operates seven flights per week on that route, each carrying roughly 290 passengers on an Airbus A330. Steven Van Gucht, one of Belgium's leading virologists, acknowledged the gravity of the situation and the logic of heightened vigilance given those direct connections. But he also noted something the historical record suggests: the actual risk to Belgium and Europe remains low.
The reason has to do with how Ebola transmits. The virus spreads only through direct contact with bodily fluids of someone who is actively sick. It does not travel through the air. Critically, people are contagious only when symptoms appear—not during the incubation period, which can last anywhere from two to twenty-one days. This window is precisely where airport temperature screening breaks down. A traveler in the early stages of infection will have no fever and will pass through any checkpoint undetected.
Celine Gossner, an expert at the European Centre for Disease Prevention and Control, told reporters that screening at entry points demands significant resources but delivers limited results. She and Van Gucht both argue that screening at departure—in the affected countries themselves—is far more effective. Still, Van Gucht acknowledged that entry screening might serve a secondary purpose: it can function as an early warning system and help reassure the public that something is being done.
Brussels Airlines is monitoring the situation closely and remains in contact with authorities. For now, all flights are operating as scheduled with no additional protective measures beyond the standard protocols crews already follow during infectious disease outbreaks. Those protocols include watching for symptoms, practicing hand hygiene, limiting contact when necessary, and cooperating with medical services if needed.
The African CDC has pushed back against broad travel restrictions, arguing they are not the solution to outbreaks and can actually hamper the humanitarian response. The European health authority agrees. The ECDC is not recommending travel restrictions, unlike the United States, which has barred entry to non-citizens who have traveled to Uganda, the DRC, or South Sudan in the past three weeks. Van Gucht rejected the idea of canceling flights from affected countries altogether, noting that such measures offer little epidemiological benefit while disrupting aid delivery and supply chains—and potentially discouraging countries from reporting cases quickly.
What Europe is doing instead is preparing its health systems. Brussels Airport has protocols in place: if an infected passenger arrives, they are evacuated by a specialized ambulance from the military hospital. The real defense, experts say, lies in early detection through healthcare providers. Travelers returning from affected areas who develop fever, headache, or general malaise within twenty-one days should seek medical care immediately and inform doctors of their recent travel. This alert system, Van Gucht argued, matters more than measuring the temperature of every arriving passenger. The priority is maintaining vigilance within European health systems and supporting the response on the ground in Africa. The ECDC is already sending experts to the DRC to help coordinate operations.
Notable Quotes
The situation in the DRC is grave and must be fought decisively on the ground. Brussels has direct connections to Kinshasa, which justifies vigilance.— Steven Van Gucht, Belgian virologist
Screening at airports requires significant resources but has limited effectiveness. Exit screening in affected countries is more effective.— Celine Gossner, European Centre for Disease Prevention and Control
The Hearth Conversation Another angle on the story
Why is Europe resisting the same screening measures the US just put in place? Doesn't that seem reckless?
It's not recklessness—it's a calculation based on how the virus actually works. Temperature checks catch people who are already sick and showing symptoms. But Ebola has an incubation period of up to three weeks where someone can be infected and contagious without running a fever. So the person passes through screening undetected anyway.
Then what's the point of any screening at all?
Screening at the source—in the DRC and Uganda—is far more effective because you're catching people before they board. And entry screening, even if imperfect, can serve as an early warning system and help maintain public confidence. But it's not a substitute for what really matters.
Which is?
Having your healthcare system ready. If someone arrives with symptoms, you need protocols to isolate them immediately. You need doctors trained to recognize Ebola. You need people to know they should report their travel history if they get sick. That's the actual defense.
But doesn't restricting travel at least slow the spread?
That's the counterintuitive part. Broad travel bans don't work epidemiologically, and they have real costs. They disrupt humanitarian aid, break supply chains, and can actually discourage countries from reporting outbreaks quickly because they fear economic punishment. The African CDC made that point explicitly.
So Europe is betting the virus won't reach them?
Not betting—assessing risk based on evidence. The virus spreads through direct contact with bodily fluids, not air. The historical record shows the risk to Europe from these outbreaks is low. That doesn't mean complacency. It means focusing resources where they actually work.